Omega 3 Supplements Market Size, Share & Trends Analysis | 2030

 

Omega 3 Supplements Market Trends
The global omega 3 supplements market size was valued at USD 7.68 billion in 2024 and is poised to grow exponentially over the next five years. Driven by a growing understanding of the profound impact that omega-3 fatty acids have on overall well-being, consumers are increasingly seeking out these supplements to optimize their health. As a result, manufacturers are responding with innovative products and marketing strategies aimed at capitalizing on this trend.

The market's growth trajectory is also being influenced by rising rates of lifestyle-related illnesses, including heart disease and arthritis. With more people than ever before looking for natural ways to manage chronic conditions, the demand for omega-3 supplements is likely to continue outpacing traditional pharmaceutical treatments.
As demographics continue to shift with an increasing aging population, consumers are turning to omega-3 supplements as a potential solution for managing age-related conditions. Government-backed initiatives and regulations have also played a significant role in driving market growth. The U.S. Food and Drug Administration (FDA), for example, has recently announced qualified health claims for EPA and DHA omega-3 consumption, highlighting their benefits in reducing the risk of hypertension and coronary heart disease.
A growing number of people are incorporating these supplements into their daily routines, driven by an increasing understanding of their potential benefits. For instance, a report by the National Institutes of Health highlights that millions of individuals in the U.S. regularly consume omega-3 supplements to support their overall health and well-being. This expanding consumer base underscores the rising awareness and acceptance of the benefits associated with omega-3 fatty acids.
When it comes to making informed purchasing decisions, consumers are influenced by a range of factors including the quality and nutritional value of products, as well as their safety. Effective awareness campaigns through various media channels can also play a significant role in shaping buying behavior, particularly when it comes to omega 3-based supplements.

As fish consumption continues to grow, especially in developing countries, demand for these products is likely to increase. However, the availability of affordable fish oil, which is the primary source of omega 3 supplements, is becoming increasingly limited due to uneven fishing practices and growing demands from other industries. This has a negative impact on market growth, making it essential for manufacturers to explore alternative sources and strategies to meet the ever-increasing demand.
Source Insights
The fish oil segment holds a leading position in the market, accounting for 61.5% of revenue share in 2024. Fish oil is widely regarded as one of the most valuable sources of EPA and DHA, two essential omega-3 fatty acids backed by substantial scientific research that underscores their numerous health benefits. These include enhanced cardiovascular well-being, improved cognitive function, and potent anti-inflammatory properties. As a result, consumers have increasingly turned to fish oil supplements due to their growing trust in the science behind these products. Moreover, the relatively low cost and increased accessibility of fish oil compared to other omega-3 sources like krill oil or algae oil make it an attractive option for health-conscious consumers. The adoption of fish oil supplements among athletes and fitness enthusiasts also drives market growth, as they utilize them for muscle recovery and joint health benefits.
Coromega recently unveiled its latest offering, Coromega Max Gold, a potent high-concentrate omega-3 fish oil supplement boasting 3,000 mg of essential fatty acids per daily dose. Comprising 1,560 mg of EPA and 1,060 mg of DHA, this premium formula is meticulously designed to promote exceptional overall wellness and cognitive function. Wild-caught, deep-sea fish are used in its creation for optimal absorption and maximum health benefits, including heart health and joint mobility support.
The krill oil segment is poised for the fastest growth trajectory over the forecast period, driven by consumer demands for eco-friendly alternatives. Krill harvesting has a lower environmental footprint compared to traditional fish oil methods, aligning with the increasing preference for sustainable products. The distinctive phospholipid composition of krill oil also improves the bioavailability of omega-3 fatty acids, allowing for enhanced absorption and utilization by the body.
Request a Free Sample Copy
https://www.theresearchinsights.com/reports/omega-3-supplements-market-146/request-sample
Form Insights
The soft gels segment is poised to experience a substantial growth trajectory over the forecast period. Consumer preference for ease of swallowing and taste masking has been a key driver in this trend, outpacing traditional tablet or capsule formats. The enhanced absorption and bioavailability offered by soft gels also contribute to their popularity, leading to faster nutrient delivery and increased effectiveness. Additionally, the convenience and user-friendly nature of soft gels make them an attractive option for consumers. Furthermore, the gelatin shell's protective properties against oxidation have been shown to extend shelf life while maintaining the quality of omega-3 oils, underscoring the benefits of this format. As a result, technological advancements and the well-documented health benefits of Omega-3 are fueling industry demand for soft gel supplements.
The capsules segment is poised for the highest growth rate during the forecast period, driven by consumer preference for a convenient and hassle-free supplement experience. By encapsulating omega-3s, these products offer precise dosing, eliminating the risk of under- or overconsumption and ensuring users receive the exact amount they need. This technology also safeguards the delicate fatty acids from oxidation and degradation, preserving their potency and efficacy.
Functionality Insights
The cardiovascular health segment accounted for the largest revenue share in 2024, driven by the growing prevalence of cardiovascular diseases among individuals aged 30 to 40 years, who tend towards an inactive and slow lifestyle. Additionally, shifting dietary patterns have also contributed to this trend. According to the American Heart Association (AHA), approximately 17.3 million people worldwide succumb to cardiovascular diseases annually, resulting in direct and indirect costs exceeding $320 billion. Furthermore, data from North America shows a higher prevalence of cholesterol levels above 43.0% and high blood pressure at 33.0%, creating a demand for pharmaceutical-grade Omega-3 supplements to treat conditions such as coronary heart disease, hypertension, and elevated cholesterol.
The eye diseases market is poised for significant growth, driven by accelerated investment in R&D and the launch of innovative products targeting nutrition-related eye conditions. The segment's trajectory is closely tied to public awareness of DHA deficiencies, leading to localized demand that is both dynamic and nuanced. To meet this demand, manufacturers are expanding their product portfolios through various formats, further fuelling growth in this key area.
End Use Insights
The segment that caters to adults aged 31-50 holds the largest revenue share in the market by 2024. This demographic is predominantly composed of working individuals with substantial purchasing power, often burdened by chronic illnesses stemming from their high-stress lifestyles. Women tend to be more proactive about maintaining a healthy lifestyle and are more inclined to integrate supplements into their wellness routines. The benefits of omega-3 fatty acids, such as alleviating anxiety and depression symptoms, reducing metabolic syndrome symptoms, mitigating inflammation, and improving mental health disorders, are expected to draw adults towards these products over the forecast period.
The infancy segment is poised for the fastest CAGR over the forecast period, driven by the critical need for optimal growth and development during this pivotal phase of life. Omega-3 fatty acids, such as EPA and DHA, are increasingly sought after as a key component in infant nutrition products due to their well-documented health benefits. Regulatory support for the inclusion of omega-3s in infant formulations has also been instrumental in driving product innovation, with manufacturers capitalizing on this trend to develop high-quality supplements. With evidence pointing to their positive impact on neurodevelopment, vision, and immune system function, it's no surprise that omega-3 supplements are becoming a staple in many infant nutrition solutions. As such, these factors are expected to propel the growth of the omega-3 supplements market for infants over the forecast period.
Distribution Channel Insights
The over-the-counter (OTC) channel has emerged as a leading force in the market, accounting for the largest revenue share in 2024. This is largely due to the widespread appeal of OTC omega-3 supplements, which offer unparalleled convenience and accessibility to consumers seeking to manage their health independently. As awareness about the health benefits of omega-3 fatty acids continues to grow, including their positive impact on heart health and cognitive function, demand for these supplements remains robust.
The prescribed channel is poised for significant growth, expected to outpace other channels by a substantial margin over the forecast period. This uptick is largely attributed to the increasing acceptance of omega-3 supplements as a viable therapeutic option for managing conditions such as hypertriglyceridemia and cardiovascular diseases. As healthcare professionals become more confident in their ability to recommend prescription-grade omega-3 supplements, patient trust in these products grows, driving market expansion. The perceived efficacy of these supplements and the growing influence of physician recommendations are key drivers fueling this segment's rapid growth trajectory.
Regional Insights
The North American omega 3 supplements industry has made a significant impact on the global market, accounting for 36.9% of total revenue share in 2024. The growing trend of using food supplements with reduced calorie levels and high nutritional content is a key driver of this growth. Additionally, increasing awareness about supplement products in Mexico due to new product launches is expected to expand the application scope of omega 3 supplements over the forecast period.

In North America, cardiac health is a primary application segment for omega 3 supplements, as heart disease remains a leading cause of death among men and women. With approximately 610,000 people dying from heart diseases in the US every year, there is a growing need for effective prevention and treatment methods. The rising awareness about the importance of diet and exercise in maintaining health and prolonging life has led to increased demand for omega 3 supplements in the region, further driving growth in this market.
U.S. Omega 3 Supplements Market Trends
The U.S. omega 3 supplements industry is poised for substantial growth over the forecast period. Consumer interest in the health advantages of omega-3 fatty acids, including enhanced heart health, cognitive function, and overall wellness, continues to rise. Furthermore, government-backed initiatives like the FDA's qualified health claims for omega-3 supplements have further elevated consumer trust and market demand. For example, the Office of Dietary Supplements within the National Institutes of Health (NIH) plays a key role in funding research and providing valuable insights into the benefits and safety of omega-3 supplements. Additionally, the FDA oversees the manufacturing and labeling of dietary supplements, ensuring that products adhere to quality standards and are free from contaminants.
Europe Omega 3 Supplements Market Trends
The European omega 3 supplements market has seen significant growth in 2024, driven by consumer increasing health awareness and demand for plant-based alternatives. As a result, the industry has experienced substantial expansion. Key players have responded by launching innovative products that cater to changing consumer preferences. In May 2024, NYO3 unveiled its Royal-boost Antarctic Krill Oil at Vitafoods Europe, showcasing cutting-edge technology designed to improve absorption rates. This new product embodies NYO3's dedication to sustainability and high-quality standards, offering consumers a pure and effective omega-3 supplement solution.
Asia Pacific Omega 3 Supplements Market Trends
The Asia Pacific omega 3 supplements industry is poised for rapid growth over the forecast period, driven by an increasing focus on health and wellness among consumers. As populations age, there is a growing emphasis on cognitive health, while high birth rates are fuelling demand for infant nutrition products. The shift towards plant-based diets has also led to a surge in demand for algae-based omega-3 supplements.

Key players such as Daewoong Bio have been at the forefront of innovation in this space, with the recent launch of CRA-TG, a combination product that pairs rosuvastatin with omega-3. This novel formulation aims to reduce triglyceride levels in patients and is part of Daewoong Bio's expanding portfolio of hyperlipidemia treatments. With improved lipid profiles and enhanced tolerability and stability, CRA-TG has demonstrated significant benefits while maintaining a similar size profile to existing products like Oma-TG.

The product features patented Multi-Layer Capsule Coating Technology, ensuring ingredient integrity and safety, making it an attractive option for consumers seeking effective omega-3 supplements. As the industry continues to evolve, innovations like CRA-TG are likely to play a significant role in shaping the future of the Asia Pacific omega 3 supplements market.
India is poised for remarkable growth during the forecast period, driven by a surge in awareness about the benefits of preventive healthcare solutions and nutritional supplements. As disposable incomes rise and urbanization intensifies, consumers are increasingly seeking out healthier lifestyle options, including dietary supplements to mitigate chronic disease risks. The growing middle-class population's adoption of Western dietary habits also fuels demand for these products. Notably, South India stands out as a key market due to its high level of health consciousness and access to nutrient-rich foods such as Omega-3.
Key Omega 3 Supplements Company Insights
The global omega 3 supplements market is dominated by several prominent players, including Nordic Naturals, a leading manufacturer of high-quality fish oil products, NutriGold, which offers a range of omega 3 supplements in various forms. Reckitt Benckiser Group PLC, a multinational healthcare company, also has a significant presence in the market through its acquisition of i-Health, Inc., a US-based company specializing in omega 3 supplements. Pharma Nord Inc., a Danish pharmaceutical company, is another major player in the industry, while AKER BIOMARINE, a Swedish company, produces high-quality fish oil products for both human consumption and industrial applications. These companies, along with several others, have established themselves as key players in the global omega 3 supplements market.
NutriGold is a leading company in the nutraceutical industry known for its high-quality supplements. These include a range of omega-3 supplements, such as the NutriGold Triple Strength Omega-3 Fish Oil. This product features 2100 mg of omega-3 per serving, providing a high concentration of EPA and DHA, which are essential for cardiovascular and brain health. NutriGold’s supplements are made using patented technology and are certified for purity and sustainability.
Reckitt Benckiser Group PLC is a global consumer health and hygiene company. The company’s focus on health and wellness includes omega-3 supplements, part of its broader portfolio to support overall health and well-being. Reckitt Benckiser’s products are developed with a strong emphasis on scientific research and innovation, ensuring high-quality and effective supplements.

Key Omega 3 Supplements Companies:
The following are the leading companies in the omega 3 supplements market. These companies collectively hold the largest market share and dictate industry trends.

Nordic Naturals
NutriGold
Reckitt Benckiser Group PLC 
Pharma Nord Inc.
i-Health, Inc.
AKER BIOMARINE
Luhua Biomarine (Shandong) Co., Ltd
KD Pharma Group SA
NOW Foods
GSK plc
Nature's Bounty

View a comprehensive list of companies in the Omega 3 Supplements Market
Recent Developments
In January 2024, Ritual launched the Omega-3 DHA + EPA supplement, offering a 500 mg dose of omega-3 fatty acids in a 2:1 ratio of DHA and EPA. Sourced sustainably from microalgae in La Forêt-Fouesnant, France, and manufactured with patented technology to reduce oxidation, the oil ensures minimal burp-back. It is infused with natural citrus oil for improved taste. Part of Ritual's Made Traceable transparency program, the supplement is vegan, third-party tested, and free from gluten, soy, and major allergens, and comes in 100% recycled packaging.
Omega 3 Supplements Market Report Scope

Report Attribute

Details

Market size value in 2025

USD 8.35 billion

Revenue forecast in 2030

USD 12.89 billion

Growth rate

CAGR of 9.1% from 2025 to 2030

Base year for estimation

2024

Historical data

2018 - 2023

Forecast period

2025 - 2030

Report updated

March 2025

Quantitative units

Revenue in USD million and CAGR from 2025 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Source, Form, Functionality, End Use, Distribution Channel, and Region

Regional scope

North America, Europe, Asia Pacific, Latin America, MEA

Country scope

U.S.; Canada; Mexico; Germany; U.K.; Italy; Norway; Spain; The Netherlands; France; China; India; Japan; Australia; New Zealand; Brazil; Argentina; UAE

Key companies profiled

Nordic Naturals; NutriGold; Reckitt Benckiser Group PLC; Pharma Nord Inc.; i-Health, Inc.; AKER BIOMARINE; Luhua Biomarine (Shandong) Co., Ltd; KD Pharma Group SA; NOW Foods; GSK plc; Nature's Bounty

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options
Global Omega 3 Supplements Market Report Segmentation
This comprehensive forecast spans across global, regional, and national levels, offering in-depth analysis of emerging trends within the omega-3 supplements market. From 2018 to 2030, our research provides a detailed breakdown of industry dynamics at sub-segment levels, offering valuable insights for stakeholders and investors alike.
Source Outlook (Revenue, USD Million, 2018 - 2030)
Fish Oil
Krill Oil
Algae Oil
Others
Form Outlook (Revenue, USD Million, 2018 - 2030)
Tablets
Capsules
Soft Gels
Others
Functionality Outlook (Revenue, USD Million, 2018 - 2030)
Cardiovascular Health
Brain, Nervous System & Mental Health
Eye Diseases
Diabetes
Others
End Use Outlook (Revenue, USD Million, 2018 - 2030)
Adults
Geriatric
Pregnant Women
Children
Infants
Distribution Channel Outlook (Revenue, USD Million, 2018 - 2028)
OTC
Supermarkets/ Hypermarkets/Food Stores
Drug Stores & Pharmacies
Online Retailers
Others
Prescribed
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Netherlands
Norway
Asia Pacific
China
Japan
India
New Zealand
Latin America
Brazil
Argentina
Middle East and Africa (MEA)
UAE